Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jun;41(6):880–885. doi: 10.1038/bjc.1980.164

Antibody-dependent cellular cytotoxicity in cancer patients: lack of prognostic value

J A McCredie, H R MacDonald
PMCID: PMC2010334  PMID: 7426312

Abstract

Antibody-dependent cellular cytotoxicity (“killer” (K) cell activity) of peripheral-blood lymphomononuclear (LMN) cells was determined in patients with early and advanced cancer, and the results compared with those in healthy individuals, those with benign diseases and critically ill septic patients. The effect of operation and local radiotherapy was determined on K cells. The initial values were compared in those who subsequently lived or died to test their prognostic value.

K-cell activity was the same in women of all ages and was half that in men. It was lower in men over 65 years than in younger men. In patients with early cancer, K-cell activity was the same as in healthy individuals and those with benign diseases, and was of no prognostic value. It was decreased by 42% in those with advanced cancer but to the same extent as in the septic patients. Operation had no effect in those who had normal activity before operation, but caused an 84% decrease in those who had low preoperative values. The decrease was maximal at 5 days and recovery occurred by 15 days. Radiotherapy caused a 72% decrease in K-cell activity, maximal at 5 weeks after starting treatment, with recovery by 16 weeks in those who had complete tumour regression. The values remained low in those with persistent tumour or metastases. The values during treatment did not help in identifying those who subsequently lived or died.

Full text

PDF
880

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cerottini J. C., Engers H. D., Macdonald H. R., Brunner T. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med. 1974 Sep 1;140(3):703–717. doi: 10.1084/jem.140.3.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  3. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  4. Jerrells T. R., Dean J. H., Herberman R. B. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients. Int J Cancer. 1978 Mar 15;21(3):282–290. doi: 10.1002/ijc.2910210306. [DOI] [PubMed] [Google Scholar]
  5. Kiessling R., Haller O. Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol. 1978;8:171–201. doi: 10.1007/978-1-4684-0922-2_6. [DOI] [PubMed] [Google Scholar]
  6. MOELLER E. CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS. Science. 1965 Feb 19;147(3660):873–879. doi: 10.1126/science.147.3660.873. [DOI] [PubMed] [Google Scholar]
  7. MacDonald H. R., Bonnard G. D., Sordat B., Zawodnik S. A. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol. 1975 Sep;4(5-6):487–497. doi: 10.1111/j.1365-3083.1975.tb02654.x. [DOI] [PubMed] [Google Scholar]
  8. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  9. McCredie J. A., Austin T. W., Holliday R. L., Sibbald W. J. Predictive value for survival of lymphocytes and polymorphonuclear leukocytes in patients with sepsis. Can J Surg. 1979 Sep;22(5):447–451. [PubMed] [Google Scholar]
  10. McCredie J. A., MacDonald H. R., Wood S. B. Effect of operation and radiotherapy on antibody-dependent cellular cytotoxicity. Cancer. 1979 Jul;44(1):99–105. doi: 10.1002/1097-0142(197907)44:1<99::aid-cncr2820440118>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  11. Ota D. M., Copeland E. M., 3rd, Corriere J. N., Jr, Dudrick S. J. The effects of nutrition and treatment of cancer on host immunocompetence. Surg Gynecol Obstet. 1979 Jan;148(1):104–111. [PubMed] [Google Scholar]
  13. Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
  14. Stratton M. L., Herz J., Loeffler R. A., McClurg F. L., Reiter A., Bernstein P., Danley D. L., Benjamini E. Antibody-dependent cell-mediated cytotoxicity in treated and nontreated cancer patients. Cancer. 1977 Sep;40(3):1045–1051. doi: 10.1002/1097-0142(197709)40:3<1045::aid-cncr2820400312>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  15. Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977 Feb;37(2):413–418. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES